我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

心房颤动对心力衰竭患者预后的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第1期
页码:
87-88,94
栏目:
临床研究
出版日期:
2008-01-20

文章信息/Info

Title:
Effect of atrial fibrillation on longterm prognostic factors in patients with heart failure
作者:
陈志术1陈志跃2辛苏萍1沈亚萍1
1.江苏大学附属武进医院心内科,江苏 常州 213000;2.宁波第二医院,浙江 宁波 315010
Author(s):
CHEN Zhishu1 CHEN Zhiyue2 XIN Suping1 SHEN Yaping1
1.Wujin Hospital, Jangsu University, Changzhou 213002, Jiangsu, China; 2.Second Hospital of Ningbo City, Ningbo 315010, Zhejiang, China
关键词:
心房颤动心力衰竭远期不良事件预后因素
Keywords:
atrial fibrillation heart failure longterm cardiac event prognostic factor
分类号:
R541.75
DOI:
-
文献标识码:
A
摘要:
目的 探讨心房颤动(AF)对心力衰竭(HF)患者远期预后的影响。方法 回顾性研究63例HF患者,根据HF是否并发AF的临床特点:分有AF组(A组),无AF组(B组),并随访(23±8)月,观察AF对HF远期不良事件发生及预后的影响。结果 ①左心房内径,A组大于B组 [(49±8)mm vs (43±7)mm,P<0.05];左心室射血分数,A组低于B组 [(33±5)% vs (42±6)%,P<0.05]; ②脑栓塞发生率,A组高于B组 (26% vs 6%,P<0.05); ③快速性心律失常,A组高于B组( 77% vs 47%,P<0.05); ④不良事件发生:A组因HF加重或脑栓塞发生的再住院率高于B组(P<0.01); ⑤病死率:A组多于B组 (32% vs 13%,P<0.01)。结论 HF基础上发生AF,预示着对原发性心脏疾病的远期不良事件发生增多,预后影响较大。
Abstract:
AIM To explore the effect of atrial fibrillation (AF) on longterm prognostic factors in patients with heart failure (HF). METHODS Sixtythree patients were divided into AF group (group A) and nonAF group (group B) and their clinical outcomes were followed up for 23±8 months. RESULTS ① The left cardiac atrium inner diameter in group A was larger than that in group B [(49±8)mm vs (43±7)mm, P<0.05] and the left ventricular ejection fraction in group A was lower than that in group B [(33±5)% vs (42±6)%, P<0.05] ② The incidence of cerebral embolism in group A was higher than that in group B (26% vs 6%, P<0.05) ③ The ventricular rate and ventricular tachyarrhythmia in group A were higher than those in group B (77% vs 47%, P<0.05) ④ Group A, due to HF aggravation or cerebral embolism, had higher rehospitalization rate than group B (46 vs 29, P<0.01)⑤ The death rate in group A was higher than that in group B (32% vs 13%,P<0.01). CONCLUSION Atrial fibrillation in patients with heart failure enhances the risk of primary heart disease, influences the prognosis and increases the disability rate and death rate.

参考文献/References

[1] Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women[J]. Mayo Clin Proc, 2001,76(5) 467-475.

[2] Deedwania PC, singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHFSTAT). The Department of Veterans Affairs CHFSTAT Investigators [J]. Circulation, 1998,98 (23):2574-2579.

[3] Khand AU, Rankin AC, Kaye GC, et al. Systematic review of the management of atrial fibrillation in patients with heart failure [J]. Eur Heart J,2000,21 (8):614-632.

[4] Friberg J, scharling H, Gadsboll N, et al. Sexspecific increase in the prevalence of atrial fibrillation (The Copenhagen city Heart study) [J]. Am J Cardial,2003,92 (12):1419-1423.

[5] Sun H, Leblanc N, Nattel S. Effects of atrial tachycardia on intracellular Ca2+ and cellular contractility [J].Circulation, 1999,100 (suppl I) :I200(abstract).

[6] Cugno M, Mari D, Meroni PL, et al. Haemos tatic and inflammatory biomarkers in advanced chronic heart failure : role of oral anticoagulants and successful heart Transplantation [J] .Briheamatol,2004,126(1):85-92.

[7] Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study [J]. Circulation, 1998 ,98(10):946-952.

[8] Caro JJ, Flegel KM, Orejuela ME, et al. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual pratice [J]. CMAJ, 1999,161(19):493-497.

[9] Mathew J, Hunsberger S, Fleg J,et al. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure [J].Chest, 2000,118 (4):914-922.

备注/Memo

备注/Memo:
收稿日期:2006-10-17.作者简介:陈志术,副主任医师Email:mnkbtcxc@126.com
更新日期/Last Update: